# Modeling of Regional Citrate Anticoagulation With a Dialysate Containing Calcium in Intermittent Hemodialysis (MARC)

> **NCT04530175** · — · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 30 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **OTHER:** blood sampling

## Key facts

- **NCT ID:** NCT04530175
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-02
- **Primary completion:** 2021-07-07
- **Final completion:** 2021-07-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530175, "Modeling of Regional Citrate Anticoagulation With a Dialysate Containing Calcium in Intermittent Hemodialysis (MARC)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04530175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*